Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone/metformin fixed combination versus glimepiride plus metformin for diabetic dyslipidemia
2006-004455-37Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2007
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone, metformin and glimepiride in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Takeda. Primary endpoint: Mean increase in HDL cholesterol. Started Apr 2007; status: completed.
02
Drugs
pioglitazonemetforminglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-004455-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004455-37.